Novo Nordisk Foundation
Center for Basic Metabolic Research

News - Clemmensen Group

ERC grant funds research to support weight loss maintenance

Associate Professor Christoffer Clemmensen from the University of Copenhagen has received an ERC Consolidator Grant for a project that aims to develop new therapeutic interventions that will help people maintain weight…

Where are they now?

“I reflected on what I enjoy doing day-to-day and aligned that with the opportunities I came across”

Nicole Fadahunsi came to Denmark from the UK to do her PhD in neuroscience with the Clemmensen Group at CBMR. Last year, she joined Lundbeck as a scientist in the department of circuit biology.

Obesity may not wreck the body’s defense system against weight gain

When people overeat for a period, their brain helps to reduce their appetite to compensate afterwards. This natural defense against weight gain might be less effective in people with obesity.

Ascending Investigators

Two CBMR scientists receive DKK 10M Ascending Investigator Grants

What is the difference between body fat in people with metabolic disease and those without? Can a better understanding of the brain’s role in obesity help to develop better drugs to treat the disease? These are the two…

Research spin outs

Two CBMR Group Leaders join the BioInnovation Institute’s Venture Lab program

Scientists at the Novo Nordisk Foundation Center for Basic Metabolic Research (CBMR) study metabolic health and disease in the hope that their discoveries will lead to new prevention and treatment strategies.

The body produces new satiety factor during prolonged exercise

The hormone GDF15 is released in response to vigorous exercise, but likely not in sufficient quantity to affect behavior or appetite.

Bioscience PhD Programme

“I was quite amazed when I arrived at CBMR”

We spoke to PhD student Nicole Fadahunsi about what drew her to CBMR, how the Center supports her scientific ambitions, and how to have a healthy work-life balance.

Research translation

CBMR scientists win innovation funding to develop new anti-cancer and obesity drugs

The BioInnovation Institute (BII) has awarded two grants worth DKK 3.5M each to CBMR to develop new drugs based on its basic metabolic research.

Scientists sound the alarm: Lockdowns may escalate the obesity epidemic

Locking down society to combat COVID-19 creates psychosocial insecurity that leads to obesity. Counter measures are needed if we are to keep the public both metabolically healthy and safe from the coronavirus

Unsolved mystery

Scientists search for the signal that stops us from gaining weight

The body might have an undiscovered defense against gaining too much weight – a signal that tells our brain to dampen our appetite. This is a theory being developed by researchers at CBMR.